Ceftobiprole medocaril
Ceftobiprole medocaril
Ceftobiprole medocaril (pronunciation: sef-toe-bi-prole me-do-ca-ril) is a broad-spectrum antibiotic used in the treatment of a variety of bacterial infections. It is a prodrug of the active compound ceftobiprole.
Etymology
The name "Ceftobiprole medocaril" is derived from its parent compound "ceftobiprole", which is a third-generation cephalosporin antibiotic. The suffix "-medocaril" indicates that it is a prodrug, which is a biologically inactive compound that can be metabolized in the body to produce an active drug.
Usage
Ceftobiprole medocaril is used to treat a wide range of bacterial infections, including skin and soft tissue infections and pneumonia. It is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
Mechanism of Action
As a prodrug, ceftobiprole medocaril is converted into its active form, ceftobiprole, in the body. Ceftobiprole inhibits the synthesis of the bacterial cell wall, leading to cell death.
Related Terms
- Antibiotic
- Bacterial infection
- Cephalosporin
- Methicillin-resistant Staphylococcus aureus
- Pseudomonas aeruginosa
- Prodrug
- Skin and soft tissue infection
- Pneumonia
External links
- Medical encyclopedia article on Ceftobiprole medocaril
- Wikipedia's article - Ceftobiprole medocaril
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski